Skip to content

TVRD - Tvardi Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchT

Tvardi Therapeutics, Inc.

TVRD · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

T

TVRDTvardi Therapeutics, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $43.65
52-wk low: $1.50
Prev close: $20.99
Mkt cap: $25.1M
P/S: 559.6x
P/B: 3.0x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$2.1M

SP
Slate Path Capital
David Greenspan · Q2 2026 13F
$1.3M
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported May 8, 2026

Earnings came in 12.3% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $25M

Valuation

P/S559.61
P/B3.02

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: TVRD
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $25.08M

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-237.8%

$174K

position

SQ

Squarepoint

Q1 2026 13F

$104K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for TVRD

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.73-12.3%

-$0.65 expected

Next report

What the street expects next

EPS expected

-$0.63

-$1.06 to -$0.41

Revenue expected

$0.00

8 analysts

Last 30 days

1up1down

Split both ways

Estimate drift

0.10

Change in 30 days

-237.8%

ROA-68.6%

Growth